Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aurinia Pharm Ord (NQ: AUPH ) 7.340 -0.020 (-0.27%) Streaming Delayed Price Updated: 2:01 PM EDT, Oct 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Aurinia Pharm Ord < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences May 14, 2021 From Aurinia Pharmaceuticals Inc. Via Business Wire Heavy Global Erosion May 11, 2021 It is an everything-down day. Even the news is down because commenters are being careful. Via Talk Markets Aurinia Unveils Patient Navigation Grant Program to Address Access Barriers for Individuals Living with Lupus and Lupus Nephritis May 10, 2021 From Aurinia Pharmaceuticals Inc. Via Business Wire Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety Aurinia Pharma Stock Showing A Potential Reversal Pattern: 4 Key Levels To Watch April 20, 2021 Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) was trending Tuesday afternoon poss... Via Benzinga The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron May 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings May 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... Via Benzinga Exposures COVID-19 Product Safety Stocks That Hit 52-Week Lows On Monday May 10, 2021 Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT).... Via Benzinga Aurinia Pharma's Stock Gains After Lupkynis Data From Late-Stage Lupus Nephritis Study Published In Lancet May 10, 2021 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has announced that The Lancet published its Phase 3 AURORA 1 study evaluating Lupkynis (voclosporin) in adults with... Via Benzinga Aurinia Announces Publication of AURORA 1 Phase 3 Study Results with LUPKYNIS™ (voclosporin) in The Lancet May 10, 2021 From Aurinia Pharmaceuticals Inc. Via Business Wire Calm Markets Day May 07, 2021 Despite seriously disappointing April jobless numbers, markets are gaining all the same. Via Talk Markets 70 Biggest Movers From Friday May 10, 2021 Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday. Velocity Financial, Inc. (NYSE: VEL) rose 36.6% to close at $12.50 following Q1... Via Benzinga Cramer Shares His Thoughts On Atkore, Petco And More May 07, 2021 On CNBC's "Mad Money Lightning Round," Jim Cramer said he prefers American Electric Power Company Inc (NASDAQ: AEP) over Consolidated Edison, Inc. (NYSE: ED). If... Via Benzinga 56 Stocks Moving In Friday's Mid-Day Session May 07, 2021 Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321. Regional Health Properties, Inc. (NYSE: RHE) gained 43% to $21.40 after dropping 23% on Thursday.... Via Benzinga Stocks That Hit 52-Week Lows On Friday May 07, 2021 Friday's morning session saw 17 companies set new 52-week lows. Key Facts: Beyond Meat (NASDAQ:BYND) was the largest firm on a market cap basis to set a new 52-... Via Benzinga The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs May 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... Via Benzinga 32 Stocks Moving in Friday's Pre-Market Session May 07, 2021 Gainers Assertio Holdings, Inc. (NASDAQ: ASRT) shares rose 44.2% to $0.7190 in pre-market trading after the company reported better-than-expected Q1 results. iBio, Inc. (NYSE:... Via Benzinga Why Aurinia Pharmaceuticals Stock Is Crashing Today May 06, 2021 Expectations for the biotech's first-quarter sales may have been too high. Via The Motley Fool Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights May 06, 2021 From Aurinia Pharmaceuticals Inc. Via Business Wire The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom May 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety Aurinia Pharmaceuticals to Release First Quarter 2021 Financial Results on May 6, 2021 April 28, 2021 From Aurinia Pharmaceuticals Inc. Via Business Wire The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue April 21, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday April 20, 2021 Tuesday's morning session saw 33 companies set new 52-week lows. Highlights: The largest company by market cap to set a new 52-week low was iQIYI (NASDAQ:IQ).... Via Benzinga The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex April 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,... Via Benzinga Aurinia Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference April 15, 2021 From Aurinia Pharmaceuticals Inc. Via Business Wire Heavy News Day - Cheats April 08, 2021 US job losses were up 744,000 vs a forecast of 694,000. Via Talk Markets The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data April 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) Aclaris Therapeutics, Inc... Via Benzinga Exposures Product Safety Aurinia's Lupkynis Shows Treatment Benefit In Lupus Nephritis, Additional Efficacy Data Shows April 08, 2021 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has presented additional efficacy data from the AURA-LV and AURORA 1 trials of Lupkynis (voclosporin) in lupus... Via Benzinga Aurinia Presents Data Demonstrating LUPKYNIS™ (voclosporin) Efficacy Across Lupus Nephritis Biopsy Classes at National Kidney Foundation 2021 Spring Clinical Meetings April 08, 2021 From Aurinia Pharmaceuticals Inc. Via Business Wire Aurinia Stock Has Great Potential, but It’s Not a Buy Right Now April 07, 2021 AUPH stock still has to prove its Lupus drug can sell and its price and the competition make that an unclear proposition. Via InvestorPlace < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
